NATCO PHARMA
|
The Current P/E Ratio of NATCO PHARMA is 8.49.
Share Price | ₹883.5 | Apr 29,2025 |
Market Cap | ₹15,823.5 Cr | |
Earnings-TTM | ₹1,863.7 Cr | TTM-Consolidated Results |
Price/Earnings | 8.49x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of NATCO PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹15,823.5 Cr] as on Apr 29,2025
(/) Earnings [ ₹1,863.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 8.49x ]
Thus, for NATCO PHARMA , the investors are currently willing to pay 8.49 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NATCO PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of NATCO PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of NATCO PHARMA
PE Ratio Performance Analysis for NATCO PHARMA
- NATCO PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 32.42x.
- NATCO PHARMA 's operated at median p/e ratio of 19.99x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NATCO PHARMA 's p/e ratio peaked in Mar2022 at 81.3x.
- NATCO PHARMA 's p/e ratio hit its five-year low in Mar2024 of 12.27x.
How does NATCO PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
NATCO PHARMA | 1,863.70 | 8.49 | 15,823.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 37.70 | 433,032.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 78.50 | 162,252.0 |
CIPLA LTD | 5,000.43 | 24.89 | 124,457.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 60.38 | 112,425.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.08 | 98,152.8 |
MANKIND PHARMA LTD | 2,050.73 | 51.45 | 105,505.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.46 | 89,348.5 |
LUPIN LTD | 2,892.10 | 32.64 | 94,400.9 |
AUROBINDO PHARMA LTD | 3,500.25 | 20.07 | 70,259.6 |
ABBOTT INDIA LTD | 1,334.46 | 47.92 | 63,948.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NATCO PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 8.49x |
Max industry PE | 78.50x |
Median industry PE | 32.64x |
Average industry PE | 36.33x |
You may also like the below Video Courses